Zheng, Qingfei http://orcid.org/0000-0002-8397-3507
Omans, Nathaniel D.
Leicher, Rachel
Osunsade, Adewola http://orcid.org/0000-0001-6340-8765
Agustinus, Albert S. http://orcid.org/0000-0002-2700-6475
Finkin-Groner, Efrat
D’Ambrosio, Hannah
Liu, Bo
Chandarlapaty, Sarat http://orcid.org/0000-0003-4532-8053
Liu, Shixin
David, Yael
Article History
Received: 13 August 2018
Accepted: 22 February 2019
First Online: 20 March 2019
Competing interests
: S.C. has received research funds from Daiichi-Sankyo (to institution), Novartis (to institution), Sanofi (to institution), Genentech (to institution) and Eli Lilly (to institution) and ad hoc consulting honoraria from Novartis, Sermonix, Eli Lilly, Context Therapeutics, and Revolution Medicines. All the other authors declare no competing interests.